Key update provides operators invaluable control and reliability in environments where GNSS/GPS signals are compromised, jammed, or entirely unavailable  WICHITA, Kan., April 23, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE:UAVS) ("AgEagle" or the "Company"), a leading provider of best-in-class unmanned aerial systems (UAS) and sensors for military, public safety, and commercial use, announces the launch of its eBee VISION next generation application software featuring a variety of critical up ...

文章核心观点 - 临床阶段制药公司Plus Therapeutics宣布任命Kyle Guse为董事会成员，其将担任审计委员会主席并加入薪酬委员会，Kyle Guse丰富经验有望助力公司发展 [1][2] 公司动态 - Plus Therapeutics宣布任命Kyle Guse为董事会成员，他将担任审计委员会主席并任职于薪酬委员会 [1] 被任命人情况 - Kyle Guse有30年专业经验，曾担任Atossa Therapeutics首席财务官等职，现担任DDC Enterprise首席法律官 [2] - 他曾是国际顶级律师事务所合伙人，也曾是四大会计师事务所注册会计师，拥有圣克拉拉大学法学博士学位和加州州立大学萨克拉门托分校工商管理硕士学位 [3] 各方评价 - 公司总裁兼首席执行官Marc H. Hedrick称Kyle Guse经验将对董事会产生积极影响，有助于执行公司商业计划和提升股东价值 [2] - Kyle Guse认为公司在治疗和诊断市场有重大机会，有潜力影响市场，期待与董事会和管理层合作发挥公司潜力 [4] 公司概况 - Plus Therapeutics总部位于德克萨斯州休斯顿，是临床阶段制药公司，开发中枢神经系统难治癌症的靶向放射疗法，结合图像引导局部β辐射和靶向药物递送方法推进产品管线，通过战略伙伴关系建立供应链 [4]

SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. ("UNITY") (NASDAQ:UBX), a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that the peer-reviewed journal NEJM Evidence published results from the Phase 2 BEHOLD study of UBX1325 in patients with diabetic macular edema (DME). As reported in the article titled, "Safety and Efficacy of Senolytic UBX1325 in Diabetic Macular Edema," the results suggested that the sel ...

DALLAS, April 23, 2025 (GLOBE NEWSWIRE) -- Westwood Holdings Group, Inc. (NYSE:WHG) will release its first quarter 2025 earnings after the close of the New York Stock Exchange on Wednesday, April 30, 2025. Following the release, the Company will host a live audio webcast and conference call at 4:30 pm Eastern Time (3:30 pm Central Time). To join the conference call, please register here: https://register-conf.media-server.com/register/BI848844d99e514a3ba97ad4fbad4288af. After registering, you will be provid ...

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (NASDAQ:TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced it will host a conference call and live webcast at 8:30 a.m. ET on Monday, April 28, 2025, to review updated safety and efficacy data from the ongoing Phase 2 open-label ADVANCED-2 trial of TARA-002 in patients with non-muscle invasive bladder cancer (NMIBC), including data from patients who have rea ...

DALLAS, April 23, 2025 (GLOBE NEWSWIRE) -- Berry Corporation (bry) (NASDAQ:BRY) ("Berry" or the "Company") today provided an update on its hedge and liquidity position, further bolstering the Company's financial strength and visibility in the current commodity price environment. The Company raised the average hedged price in 2026 and 2027 by $6 per barrel on 2.3 MBbls/d. The Company's oil volumes are 73% hedged for the remainder of 2025 and 63% hedged for 2026, based on the midpoint of Berry's full year 202 ...

Beijing, April 23, 2025 (GLOBE NEWSWIRE) -- WiMi Developed a Quantum Computing-Based Feedforward Neural Network (QFNN) Algorithm BEIJING, Apr. 23, 2025––WiMi Hologram Cloud Inc. (NASDAQ:WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, announced the development of a Quantum Computing-Based Feedforward Neural Network (QFNN) algorithm aimed at overcoming computational bottlenecks in traditional neural network training. The core innovation of this algorith ...

SAN MATEO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. ((Sagimet, NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that three poster presentations featuring additional analyses from the Phase 2b FASCINATE-2 study of denifanstat in MASH will be presented at the European Association for the Study of Liver (EASL) Congress 2025 being held May 7-10, 2025 in Amsterdam, Netherlands ...

BOCA RATON, FL, April 23, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corporation (NASDAQ:JNVR) (the "Company") today announced the appointment of Fei "John" Han as Chief Financial Officer, as well as Dan Kang ("DK") as Head of Investor Relations. The new appointments underscore the Company's commitment to building a world-class financial and investor relations function as it scales its crypto-forward treasury strategy. Han brings over 15 years of experience across traditional finance and crypto, with a track ...

SHANGHAI and BURLINGTON, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Just ahead of Auto Shanghai 2025, Cerence Inc. (NASDAQ:CRNC) ("Cerence AI"), a global leader pioneering conversational AI-powered user experiences, today announced a new partnership with MediaTek and expanded collaboration with NVIDIA to deliver the next generation of CaLLM™ Edge, its embedded small language model (SLM) purpose-built for automotive user experiences. With new multi-modal capabilities powered by NVIDIA AI Enterprise software, ...